Correlation Between Merck and Organon

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Merck and Organon at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck and Organon into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merck Company and Organon Co, you can compare the effects of market volatilities on Merck and Organon and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of Organon. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and Organon.

Diversification Opportunities for Merck and Organon

0.93
  Correlation Coefficient

Almost no diversification

The 3 months correlation between Merck and Organon is 0.93. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and Organon Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Organon and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Company are associated (or correlated) with Organon. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Organon has no effect on the direction of Merck i.e., Merck and Organon go up and down completely randomly.

Pair Corralation between Merck and Organon

Considering the 90-day investment horizon Merck Company is expected to under-perform the Organon. But the stock apears to be less risky and, when comparing its historical volatility, Merck Company is 1.87 times less risky than Organon. The stock trades about -0.01 of its potential returns per unit of risk. The Organon Co is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  1,235  in Organon Co on September 12, 2024 and sell it today you would earn a total of  334.00  from holding Organon Co or generate 27.04% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy100.0%
ValuesDaily Returns

Merck Company  vs.  Organon Co

 Performance 
       Timeline  
Merck Company 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Merck Company has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Organon 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Organon Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of sluggish performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Merck and Organon Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Merck and Organon

The main advantage of trading using opposite Merck and Organon positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, Organon can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Organon will offset losses from the drop in Organon's long position.
The idea behind Merck Company and Organon Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Bonds Directory
Find actively traded corporate debentures issued by US companies
Fundamental Analysis
View fundamental data based on most recent published financial statements
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency